An amplification of the genomic region 11q22 that spans over the cIAP1 and cIAP2 genes is associated with lung cancers [61], cervical cancer resistance to radiotherapy [62], and oesophageal squamous cell carcinomas [63]. This evidence concerns the gene BIRC3 and cervical carcinoma.